The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 756K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

10 articles for JF Miller


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 1. Discovery of a novel series of potent antihyperglycemic and antihyperlipidemic agents.EBI
Glaxo Wellcome Research and Development
Hepatitis C replication inhibitors that target the viral NS4B protein.EBI
Glaxosmithkline
Ultra-potent P1 modified arylsulfonamide HIV protease inhibitors: the discovery of GW0385.EBI
Glaxosmithkline
Synthesis and SAR of novel isoquinoline CXCR4 antagonists with potent anti-HIV activity.EBI
Glaxosmithkline
Novel N-substituted benzimidazole CXCR4 antagonists as potential anti-HIV agents.EBI
Glaxosmithkline
Incorporation of a chiral gem-disubstituted nitrogen heterocycle yields an oxazolidinone antibiotic with reduced mitochondrial toxicity.EBI
California Institute of Technology
Imidazopyridazine hepatitis C virus polymerase inhibitors. Structure-activity relationship studies and the discovery of a novel, traceless prodrug mechanism.EBI
Glaxosmithkline Research & Development
Non-nucleoside reverse transcriptase inhibitorsBDB
Merck Sharp & Dohme
Androgen receptor antagonistsBDB
University of California
Tetrahydro-benzodiazepinonesBDB
Hoffmann-La Roche